Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?

Anne K EllisRémi GagnonEva HammerbyAndrea Lau

Published in: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology (2019)

The CMA indicates that SQ HDM SLIT-tablets are a cost-minimizing alternative to HDM SCIT when considered from a societal perspective in Ontario and Quebec.

Keyphrases

allergic rhinitis
risk assessment
health risk
replacement therapy
climate change
heavy metals
human health
drinking water
health risk assessment